Epigenetic alterations caused by viral oncoproteins are strong initiation factors for cancer development, but their mechanisms are largely unknown. To identify the epigenetic effects of viral hepatitis B virus X (HBx) that lead to hepatocellular carcinoma (HCC), we profiled the DNA methylomes of normal and HBx transgenic mouse liver. Intriguingly, severe hypomethylation of intragenic CpG islands (CGIs) was observed in HBx liver before the full development of HCC. Normally, these CGIs were highly methylated (mCGIs) by the DNMT3L complex and marked with epigenetic signatures associated with active expression, such as H3K36me3. Hypomethylation of mCGI was caused by the downregulation of Dnmt3L and Dnmt3a due to HBx bound to their promoters, along with HDAC1. These events lead to the downregulation of many developmental regulators that could facilitate tumorigenesis. Here we provide an intriguing epigenetic regulation mediated by mCGI that is required for cell differentiation and describe a previously unidentified epigenetic role for HBx in promoting HCC development.
Epigenetic alterations caused by viral oncoproteins are strong initiation factors for cancer development, but their mechanisms are largely unknown. To identify the epigenetic effects of viral hepatitis B virus X (HBx) that lead to hepatocellular carcinoma (HCC), we profiled the DNA methylomes of normal and HBx transgenic mouse liver. Intriguingly, severe hypomethylation of intragenic CpG islands (CGIs) was observed in HBx liver before the full development of HCC. Normally, these CGIs were highly methylated (mCGIs) by the DNMT3L complex and marked with epigenetic signatures associated with active expression, such as H3K36me3. Hypomethylation of mCGI was caused by the downregulation of Dnmt3L and Dnmt3a due to HBx bound to their promoters, along with HDAC1. These events lead to the downregulation of many developmental regulators that could facilitate tumorigenesis. Here we provide an intriguing epigenetic regulation mediated by mCGI that is required for cell differentiation and describe a previously unidentified epigenetic role for HBx in promoting HCC development.
DNA methylation | methylated CpG island | viral protein H epatocellular carcinoma (HCC) is one of the most dangerous cancers that threaten many people, especially those with hepatitis B or C virus (HBV or HCV) (1) (2) (3) . However, the exact mechanisms underlying HCC are not clear because there are multiple factors, including chronic inflammation (4), genetic alteration caused by viral integration into the host genome (5) , and the oncogenic actions of viral proteins (6) . Although many studies have previously demonstrated that these factors, alone or in combination with other factors, are able to initiate tumorigenesis (1), the oncogenic potential of viral protein in cancer development is one of the most interesting exogenic factors that facilitates tumorigenesis, in particular, through the epigenetic regulation of infected cells (7) .
Epigenetic alterations in cancer cells are now regarded as one of the most important factors driving cancer initiation. Abnormal DNA methylation is the most frequently found change in many cancers and is believed to control associated gene expression without altering the DNA sequence itself (8) . The transcriptional silencing of tumor suppressor genes associated with the hypermethylation of promoter regions is a typical epigenetic change in many cancers (9) . The DNA hypomethylation in repeat sequences and transposable elements is known to induce chromosomal instability and mutation events (10) that lead to cancer development and progression (11) . In addition, various types of cancer cells exhibit abnormal expression levels of DNA methyltransferase (DNMT) families, which probably causes global changes in DNA methylation (12) .
In mammalian cells, large clusters of CpG dinucleotides known as CpG islands (CGIs) appear to act as a key epigenetic element regulating gene expression. Most CGIs are found at the 5′ end of transcripts and behave as functional promoters (13) .
Some unmethylated intragenic and intergenic CGIs contain distinct epigenetic markers and work as enhancers or alternative promoters, demonstrating the regulatory potential of CGIs. Although most promoter associate CGIs are unmethylated, about 20-30% of CGIs found in the gene body are highly methylated (13) and suggested as marking actively transcribed regions (14) or as suppressing promoters for antisense transcripts (15) .
The HBV x (HBx) protein, which plays a critical role in the development of HCC, was shown to interact with several epigenetic factors, such as DNMT3A and HDAC1 (16) . However, the physiological significance of these interactions and the regulatory mechanism leading to gene silencing are not clear. HBx was shown to recruit DNMT3A to certain promoters to repress their activities through de novo DNA methylation; however, HBx also causes hypomethylation in certain promoters, possibly via the redistribution of DNMT3A to other promoters (16) . In Significance Epigenetic dysregulation by oncoviral protein plays a key role in tumor development. DNA methylome analysis of hepatitis B virus X (HBx)-induced hepatocellular carcinoma (HCC) revealed drastic changes in host epigenome, but in an unconventional way: intragenic CpG islands (CGIs) were dramatically demethylated. We showed methylated intragenic CGIs as previously unidentified regulatory elements associated with active expression. The methylated CGIs are marked with distinct epigenetic signatures and require DNA methyltransferase (DNMT) 3L complex for their high methylation levels. By directly suppressing Dnmt3L and Dnmt3a promoters, HBx induces hypomethylation of the intragenic CGIs and downregulation of the associated developmental regulators. We provide previously unreported functional identification of intragenic CGIs that may enhance our understanding of epigenetic regulation and a new epigenetic role for HBx in promoting HCC development. addition, as a transcriptional activator, HBx modifies diverse signal transduction pathways that mediate cellular transformation (17, 18) . Most HBx transgenic (17) mice spontaneously develop HCC at about 1 y of age, providing genetic validation of the oncogenic potential of HBx even in the absence of viral integration and chronic inflammation (6) .
To address the role of HBx viral oncoprotein in the development of HCC, specifically the aspect of epigenetic regulation of the host genome, we examined the differences in DNA methylation patterns between normal and HBx-induced liver cancer cells. Intriguingly, DNA methylome analysis revealed dramatic demethylation mainly in the intragenic CGIs with concurrent downregulation of the affected genes. Reanalysis of the epigenome data from human cell lines revealed specific epigenetic signatures associated with a distinct group of the intragenic CGIs, indicating that they are potential epigenetic regulatory elements for active gene expression. The suppression of Dnmt3L and Dnmt3a promoters by HBx appears to cause deficient DNA methyltransferase activity in HBx transgenic (TG) mouse liver, which renders the intragenic CGIs hypomethylated. Therefore, dysregulation of the epigenetic process at the intragenic CGIs appeared to contribute to tumorigenesis. Our findings reveal an intriguing epigenetic mechanism mediated by highly methylated intragenic CGIs in the regulation of cell differentiation.
Results

Global Comparison of DNA Methylation in Normal and HBx TG Mouse
Liver. To examine the DNA methylation changes leading to cancer, we created DNA methylation maps for liver tissues from HBx TG mice and their wild-type littermates at early (3-mo-old) and late (13-mo-old) stages of tumor development (6, 19) . We sequenced the methylated DNA from at least two independent preparations for each sample using the methylated CpG island recovery assay (MIRA) (20) . To measure enrichment of methylation signals, we counted the number of overlapping reads at every 50 bp across the whole genome and then calculated RPKM (reads per million base pairs mapped per kilobase) as normalized DNA methylation values (21) (22) (23) . Each methylome contained ∼20 million sequence reads, covering ∼40% of all genomic CpG sites, excluding centromeres. The average read depth for covered each CpG was 10×, which is sufficient for reliable comparison among the samples (SI Appendix, Table S1A ).
Scatter plot analysis of the four methylomes revealed a decrease in global DNA methylation both in 3-and 13-mo-old mice with HBx-induced HCC (Fig. 1A) . The values in the scatter plots represented RPKM (at every 50 bp) of the four methylomes (Norm3 vs. HBx3, Norm13 vs. HBx13, Norm3 vs. Norm13, and HBx13 vs. HBx13). Significant methylation changes were already obvious in the early stage of transformation (Norm3 vs. HBx3) and were maintained during cancer progression (Norm13 vs. HBx13). The methylation levels did not change a lot between different ages compared with the methylation changes caused by tumor development. The differentially methylated regions (DMRs) were highly enriched in exons, with the most striking changes at CGIs in both age groups (Fig. 1B) . To understand the role of DNA methylation changes in the early stage of tumor development, we carried out additional MIRA-seq and RNA-seq analyses of the 3-mo-old age group to expand the methylation sequence reads up to 170 million for each sample, which covers more than 85% of the mouse genome with >70× coverage of the CpG site (SI Appendix, Table S1 B and C). We used these high-density methylomes of 3-mo-old normal and HBx liver to understand the detained nature of DNA methylation changes caused by HBx.
We found 10,553 tumor-associated DMRs (6,668 hypermethylated and 3,885 hypomethylated regions) with differences of at least 7 RPKM in the 3-mo-old age group. For comparison, the expected frequency of variations was normalized by the length or CpG counts of the mouse genomic structures (SI Appendix, Table S2 ). Exonic regions occupy less than 2% of the mouse genome, but ∼29 and 45% of the total hyper-and hypomethylated regions, respectively, were within this region showing 14.9 (to length) and 34.1 (to CpG counts) times higher enrichment in exons compared with the genome-wide average (SI Appendix, Table S2 A and B). Therefore, a portion of exons appeared to be highly deregulated in the HBx-induced liver cancer model at an early stage of tumor development.
Drastic Hypomethylation of Intragenic CGIs in HBx-HCC. To examine whether DMR enrichment in exons was associated with any repetitive elements, various repeats and CpG islands were analyzed for bias in DMR association. Except for demethylation of the satellite elements, HBx TG liver showed no major methylation changes in most repeats. However, CpG islands were significantly hypomethylated in HBx-induced tumor cells (SI Appendix, Table S2B ). To further study the meaning of CGI-associated demethylation, we subgrouped CGIs by their genomic locations: promoter-linked, intragenic, and intergenic CGIs (13) . About 70% of CGIs are associated with promoters, and most of the promoterassociated CGIs are methylation-free. However, a considerable percentage of the intragenic CGIs (20-34%) were highly methylated and showed variations in methylation levels among different tissues (15, 24) . Comparison of the methylation levels at these CGIs revealed that only the intragenic CGIs were drastically demethylated in the HBx TG liver (Fig. 1C) , and this was observed throughout the entire length of the CGIs without The DMR in normal and HBx TG liver of 3-and 13-mo-old mice and the relative enrichment ratio to length of genomic elements. The expected frequency of variations was normalized by the length of the mouse genomic structures. (C) Differential methylation for supgrouped CGIs depends on their genomic locations in normal and HBx TG liver of 3-mo-old mice (HBxNorm, RPKM). Differences were assessed with twotailed t tests; *P < 0.01. (D) Average plot of DNA methylation on intragenic CGI and surrounding 4-kb regions (solid line, Norm; dashed line, HBx, RPKM) Each CGI was divided into 100 bins, and surrounding 4-kb regions were plotted at 40-bp resolution. (E) Intragenic CGIs consist of exonic and intronic regions. CGIs covering exons and introns were considered exonic. Box plot shows differential methylation for exonic vs. intronic CGIs (HBx-Norm, RPKM). Differences were assessed with a two-tailed t test; ***P < 0.0001.
affecting the methylation levels of their shore regions (Fig. 1D) . Intriguingly, even for the intragenic CGIs, CGIs overlapping with exons were highly demethylated (Fig. 1E) . Considering that most CGI promoters were not affected, this result indicates that CGIs overlapping with exons might be the major targets of the cancer-associated demethylation process.
Downregulation of Genes Containing Hypomethylated Intragenic
CGIs. To understand the genetic structures associated with intragenic CGIs, we plotted the relative locations of CGIs and exons along the length of their corresponding gene structures for the 647 genes containing intragenic CGIs that were hypomethylated in HBx TG mouse liver. The DNA methylation levels in normal livers were displayed along with the levels of differential methylation and RNAs in the HBx TG mouse liver. The locations of CGIs revealed two distinct clusters, one at the promoter and the other near the 3′ end of the transcript (Fig.  2A) . The promoter-associated CGIs were methylation-free, but the CGIs overlapping mostly with the distal exons near the 3′ end of the transcripts showed a significantly high level of DNA methylation. In general, distal exons with high levels of DNA methylation showed higher levels of RNA expression (Fig. 2B) . In HBx liver, the DNA methylation level was drastically reduced, mainly at the distal exonic CGIs, along with the reduction of the transcript levels from the demethylated exons ( Fig. 2A) . Intriguingly, the negative effect of CGI hypomethylation was not limited to the associated exons. The RNA levels from the proximal exons of the hypomethylated CGIs were also concomitantly decreased (Fig. 2C) . Therefore, the high levels of DNA methylation at the distal intragenic CGIs may play an important role in maintaining high RNA expression levels.
Gene ontology analysis of the hypomethylated genes revealed a high enrichment of the genes involved in cell adhesion, embryonic morphogenesis, signaling, and transcription (SI Appendix, Table S3 and deregulated genes listed in Table S4 ), reflecting the regulatory changes associated with HBx-induced tumorigenesis. Downregulation of genes involved in epithelial-to-mesenchymal transition (E-and N-cadherins), the Smad-dependent TGF-β-signaling pathway (Smad6 and Kcp), and the Wnt-signaling pathway (Wnts) is known to play crucial roles in tumorigenesis. Indeed, these genes were downregulated in HBx-TG liver (SI Appendix, Fig. S1 ). Thus, the broad deregulation of these factors by CGI hypomethylation in HBx TG liver may contribute to tumor development.
Distinct Epigenetic Features of the Methylated Intragenic CGIs. To explore the possibility of these methylated intragenic CGIs being a distinct epigenetic element, we examined epigenetic signatures specifically associated with them. Promoter-associated CGIs found in most housekeeping genes are unmethylated and highly enriched with trimethylation of H3 lysine 4 (H3K4me3) (25) . On the other hand, intragenic CGIs marked with H3K4me3 or H3K4me1 act as "orphan promoters" and "enhancers," respectively (15, 26, 27) . Because these CGIs with distinctive histone marks are generally unmethylated, the methylated CGIs at the distal exons do not appear to act as alternative promoters/ enhancers. To validate this idea, we analyzed intragenic CGIs in the mouse genome by K-means clustering with the levels of H3K4me3, H3K4me1, and DNA methylation using mouse liver ENCODE data (28) . Intriguingly, these epigenetic markers can cluster intragenic CGIs into three distinct classes: promoter-like CGIs (pCGIs) with a high level of H3K4me3, enhancer-like CGIs (eCGIs) with intermediate levels of both H3K4me1 and H3K4me3, and the methylated CGIs (mCGIs) with high levels of only DNA methylation (Fig. 2D) . Among them, only the mCGIs were aberrantly methylated in HBx TG liver (Fig. 2E) .
To test whether the distinct types of CGIs were evolutionarily conserved features, epigenome data (29) obtained from three different types of human cell lines (HepG2, hepatocellular carcinoma; GM12878, B-lymphocyte; and K562, leukemia) were similarly analyzed. Human intragenic CGIs were also clustered into three groups (pCGI-, eCGI-, and mCGI-like) based on their levels of DNA methylation, H3K4me1, and H3K4me3 (SI Appendix, Fig. S2A ). The clustering patterns were similar in all three cell types in that most of the mCGIs in the three different cell lines overlapped (SI Appendix, Fig. S2B ) and were associated with exons (77%) (SI Appendix, Fig. S2C ). The human genes . Intragenic CGIs can be divided into three subgroups based on the levels of H3K4me3 (ENCODE), H3K4me1 (ENCODE), and DNA methylation. Average plot of H3 lysine 4 or DNA methylation on each grouped CGI and the surrounding 4-kb regions. (black, H3K4me1; blue, H3K4me3; red, DNA met, RPKM). Each CGI and the surrounding 4-kb regions were divided into 100 bins. (E) Box plot shows differential methylation for mCGIs, pCGis, and eCGIs (HBx-Norm, RPKM). Differences were assessed with a two-tailed t test; ***P < 0.0001.
containing mCGIs were also enriched with developmental regulators as observed in mouse (SI Appendix, Table S5 ). These results indicate that mCGI methylation is an epigenetic marker that is strongly associated with active RNA expression from key developmental genes.
mCGI Methylation as an "Active" Epigenetic Mark. To further characterize the distinct classes of CGIs, we examined levels of diverse epigenetic markers (H3K27me3, H3K36me3, H3K9me3, MNase, and DNase I accessibility) associated with each CGI using the human GM12878 cell line ENCODE epigenome data (29) . In addition to the high level of H3K4me3, pCGIs were characterized by a highly open chromatin structure and a high density of RNA polymerase II, whereas eCGIs were marked with a high level of H3K27me3 (Fig. 3A) . Conversely, mCGIs, found mostly in exons, were highly enriched with H3K36me3 but showed the lowest levels of H3K27me3, H3K9me3, and DNase I accessibility among the intragenic CGIs. In addition, the analysis of the mouse ENCODE epigenome data revealed an identical result (SI Appendix, Fig. S2E) .
Therefore, mCGIs appear to have a chromatin structure distinct from those found in pCGIs and eCGIs. The striking differences in DNA accessibility and histone modification marks between mCGIs and the other CGIs suggested that the levels of DNA methylation at mCGIs may be related to the levels of gene expression. Alignment of mCGIs according to their methylation levels demonstrated positive and negative correlation of methylation levels with those of H3K36me3 and H3K27me3, respectively (Fig. 3B) . Consistent with this observation, the highly methylated mCGIs showed higher expression levels (Fig. 3C) . In addition, reflecting the broad effect of mCGI methylation on RNA expression, the changes in H3K27me3 and H3K36me3 levels were not limited to mCGIs but appeared to spread out to the entire gene body (Fig. 3A and SI Appendix, Fig. S2D ).
Requirement of DNMT3L for mCGI Methylation. To examine whether the hypomethylation of mCGIs in HBx-induced HCC was caused by the loss of DNA methyltransferase activity, we examined total DNA methyltransferase activities of nuclear extracts from normal liver and HBx TG liver. Indeed, HBx TG liver samples showed reduced DNA methyltransferase activity compared with their normal counterparts (Fig. 4A) . To identify the DNMT responsible for the decreased DNA methyltransferase activity in HBx TG mouse liver, the levels of diverse DNMTs were measured by quantitative RT-PCR (RT-qPCR). Although there were no major differences in Dnmt1 and Dnmt3b transcript levels, Dnmt3L expression, along with a moderate decrease in Dnmt3a expression, was significantly decreased in HBx TG mouse liver (Fig. 4B ). DNMT3L and DNMT3A are known to play key roles in the accumulation of high levels of gene-body-associated DNA methylation during embryo development (30) . To test whether Dnmt3L-dependent gene-body methylation is mediated through the methylation of mCGIs, we analyzed DNA methylome changes in early embryos induced by partial deficiency of Dnmt3L. Genomewide comparison of the methylation levels between wild-type and Dnmt3L
−/+ mice revealed that the overall methylation defects in exons were similar to those of the HBx-TG mouse (Fig. 4C) ; in particular, mGCIs were specifically hypomethylated in the Dnmt3L −/+ mouse (Fig. 4D ). In addition, adult mouse liver had a low but significant level of Dnmt3L expression (Fig. 4E) , and the reduced levels of Dnmt3L expression correlated with the loss of DNA methylation at mCGIs of the target genes ( Fig. 4F and SI Appendix, Fig. S3 ). Therefore, the reduced expression of Dnmt3L and Dnmt3a may synergistically lower the level of functional DNA methyltransferase activity in HBx-induced HCC, which results in the reduced DNA methylation of mCGIs during early development. To examine the recruitment of DNMT3L and its associated epigenetic effect on mCGIs, the levels of DNMT3L and histone modification markers (H3K4me36 and H3K4me27) in wild-type and HBx-TG mouse liver were monitored by chromatin immunoprecipitation (IP)-coupled quantitative PCR (ChIP-qPCR) analysis. The decrease of mCGI DNA methylation levels in the target genes appeared to be related to the loss of DNMT3L bound to the region along with the epigenetic deregulation of H3K27me3 and H3K36me3 (Fig. 4G and SI Appendix, Fig. S4 ). This result suggests that defective DNMT3L expression and recruitment of the mCGIs from key developmental genes in HBx TG liver may cause abnormal epigenetic regulation that contributes to the development of hepatocellular carcinoma.
HBx-Mediated Repression of the Dnmt3L Promoter by HBx. To understand how HBx downregulated Dnmt3L expression, epigenetic factors bound to the Dnmt3L promoters were examined by ChIP. In mice, Dnmt3L is regulated via three different promoters: Dnmt3L-S (stem cell, the canonical transcript), Dnmt3L-O (oocyte), and Dnmt3L-AT (adult testis). As previously shown (31), Dnmt3L-S appears to be the major promoter in liver; most of the transcription factors examined were detected only in the Dnmt3L-S region, and no significant binding of these factors was detected in either of the germ cell-specific promoters (Fig. 5A) . The S promoter region, which contains four SP1-binding sites (32) , was highly enriched with the SP1 transcription factor and active histone mark, H3K4me3, in normal liver. However, in HBx TG liver, the levels of SP1 and H3K4me3 at the promoter were greatly diminished. Instead, the promoter in HBx TG liver was highly bound by HBx and HDAC1 (Fig. 5A) . These results indicate that the binding of HBx to the Dnmt3L-S promoter silenced the promoter by recruiting HDAC1. Dnmt3a promoter was also similarly repressed by HBx-induced epigenetic changes (SI Appendix, Fig. S5 ). In addition, the transfection of exogenous FLAG epitope-tagged HBx into HepG2 caused downregulation of DNMT3L expression specifically (Fig. 5B) , and ChIP-qPCR analysis revealed that the DNMT3L promoter was highly occupied with HBx along with HDAC1 (Fig. 5C) . Therefore, HBx appears to directly regulate DNMT expressions via epigenetic modification.
Discussion
Here we present a previously unidentified epigenetic regulatory element, mCGI, required for active expression of many genes involved in development. Several lines of evidence support mCGIs as a previously unidentified type of epigenetic regulatory element that is different from the promoter/enhancer functions attributed to other types of CGIs. First, the high abundance and depletion of H3K36me3 and H3K27me3, respectively, are associated only with mCGI. This pattern is quite different from those of other intragenic CGIs that contain high H3K4 methylation or H3K27me3 marks required for the assembly of active or repressed transcription machineries, respectively. mCGIs also appear to differ from the recently reported partially methylated domains (PMDs) (33) . Unlike the reverse correlation between methylation levels and the repressive histone modification marks H3K27me3 and H3K9me3, shown in PMDs, the hypomethylation of mCGIs did not cause higher levels of H3K9me3.
Second, the locations of mCGIs show a strong bias toward the 3′ end of the transcripts, whereas no such obvious structural restrain was found for the other intragenic CGIs. Although methylation is highly centered on mCGIs located near the end of the transcripts, their hypomethylation caused a significant shift of histone modification from active to repressive patterns, not just in the mCGIs but throughout the entire length of the mCGIcontaining genes. The specific location of mCGIs and their effect on the entire gene region suggest their regulatory potential in the maintenance of active transcription.
Third, mCGIs appear to harbor high nucleosome densities. CGIs found mostly at promoters are devoid of nucleosomes, and high DNA accessibility is an important feature required for transcription factor binding (34) (35) (36) . Similarly, pCGIs and eCGIs also show high DNA accessibility. Although we do not know how mCGIs enhance gene expression, the distinct locations near the end of a gene and the high levels of nucleosome densities associated with mCGIs hinted that an active chromatin organization mediated by specifically modified nucleosomes, rather than specific DNA-binding factors, may generate a favorable environment for active transcription. It would be intriguing to examine the distinct chromatin conformations associated with mCGIs.
Unlike most CGIs that are maintained in methylation-free states, mCGIs are highly methylated, but how this targeted methylation is achieved is not well understood. De novo CGI methylation is mediated by DNMT3A and DNMT3B, which are stimulated by DNMT3L, a nonenzymatic subunit of DNA methyltransferase (37) (38) (39) . Because the ADD domains in DNMT3A, DNMT3B, and DNMT3L bind to histone H3 only when H3K4 is not methylated, the mCGIs that are devoid of methylated H3K4 marks can be targeted specifically by the DNMT3 complex (39, 40) . In addition, the high levels of H3K36me3 associated with mCGIs also contribute to the mCGI-specific recruitment of DNMT3 complexes. The PWWP domain of DNMT3A, but not DNMT3B, can interact with H3K36me3, providing an additional link between DNA methyltransferase and mCGIs (41) . In addition to the preferential recruitment of DNMT3 complexes to the mCGIs, the Setd2 complex (H3K36 methyltransferase) enriched at the mCGIs prevents H3K4 methylation by recruiting KDM1b, a H3K4me1/2 demethylase (42). On the contrary, the loss of DNA methylation in mCGI has a part to play in recruitments of H3K4 methyltransferases (Mll1 and Cfp1/Set1) and H3K36me1/2 demethylase (Kdm2a). Their CXXC domains bind to unmethylated CpGs, resulting in depletion of H3K36 methylation and increase of H3K4 methylation (43) . Therefore, cooperative interplay between DNA methylation and histone modifications on mCGI may play an important role in maintaining high RNA expression levels.
We observed a severe decrease of mCGI methylation in HBx-HCC, which appeared to be induced by the loss of DNMT expressions. HBx bound to the promoters of Dnmt3L and Dnmt3a and recruited HDAC1 to downregulate their expressions. HBx does not bind directly to DNA but is recruited to promoters by indirectly binding to other transcription factors (44) . In addition to the transcriptional suppression of Dnmt3a and Dnmt3L, HBx can inhibit DNMT3A activity by directly binding to the enzyme (16) . Therefore, the multilayered inhibition of the DNMT3A:DNMT3L complex by HBx would result in a dramatic reduction in mCGI methylation even at the small decrease of individual subunits of DNMT complex. Indeed, we showed that the recruitment of DNMT3L at the hypomethylated mCGI is significantly decreased in HBx-induced HCC. It is intriguing that DNMT3L expression is also significantly suppressed in human HBV-positive HCC (SI Appendix, Fig. S6 ) (45) . Therefore, the reduction of de novo DNA methylation activity caused by HBx may be responsible for the abnormal cell differentiation.
Although HBx has been known to exert a pleotropic effect on diverse cellular mechanisms, the deregulation of a large number of development genes by mCGI hypomethylation appears to be one of the major factors driving tumoregenesis at least in liver. This study revealed a previously unidentified HBx function in downregulation of Dnmt3L and suggests that a restoration of proper de novo DNA methylation activity may trigger proliferative tissues to differentiate. In addition, the functional identification of the mCGI element may enhance our understanding of epigenetic regulation mediated by differential methylation during cell differentiation.
Materials and Methods
HBx transgenic mice and nontransgenic mice (C57/BL/6) were maintained according to the Guide for Animal Experiments (edited by the Korean Academy of Medical Sciences) by the Institutional Animal Care and Use Committee (IACUC) at Seoul National University.
Protocols were reviewed and approved by the IACUC of the Yonsei Laboratory Animal Research Center at Yonsei University (Permit 2008-0012) . We attempted to sequence methylated DNA from the normal liver and HBxinduced HCC samples with the aid of next-generation sequencing and MIRA (20) . The methylation levels of CGI, promoter, gene bodies, and repeat elements were estimated by means of RPKM (or means of DNA methylation percentage for bisulfite sequencing) overlapping each element. All public data were processed with the same procedures. Detailed descriptions of methods are available in SI Appendix.
